REGENXBIO, Inc. (RGNX)
7.99
-0.36
(-4.31%)
USD |
NASDAQ |
Feb 13, 16:00
7.99
0.00 (0.00%)
After-Hours: 16:09
REGENXBIO Free Cash Flow : -106.28M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Omeros Corp. | -105.32M |
| Sarepta Therapeutics, Inc. | -401.63M |
| AbbVie, Inc. | 19.68B |
| CytomX Therapeutics, Inc. | -72.35M |
| Krystal Biotech, Inc. | 165.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -55.96M |
| Cash from Investing (Quarterly) | 42.29M |
| Cash from Financing (Quarterly) | -7.083M |
| Free Cash Flow Per Share (Quarterly) | -1.092 |
| Free Cash Flow to Equity (Quarterly) | -52.90M |
| Free Cash Flow to Firm (Quarterly) | -43.28M |
| Free Cash Flow Yield | -26.06% |